SOURCE: Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP

February 03, 2015 16:00 ET

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Venaxis, Inc. (APPY) to Contact the Firm

NEW YORK, NY--(Marketwired - February 03, 2015) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Venaxis, Inc. ("Venaxis" or the "Company") (NASDAQ: APPY) of the April 3, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Venaxis and certain officers of the Company.

A complaint has been filed in the United States District Court for the District of Colorado on behalf of all persons who purchased or otherwise acquired Venaxis securities between March 13, 2014 and January 28, 2015 (the "Class Period").

The complaint alleges that the Company and its executives violated federal securities laws with respect to its statements concerning its business, operations, and prospects.

Specifically, the action alleges that during the Class Period, Venaxis misrepresented and/or failed to disclose that the Company's expected Food and Drug Administration ("FDA") clearance of the 510(k) submission of its lead product candidate, the APPY1 diagnostic test, lacked a reasonable basis.

On January 29, 2015, Venaxis announced that the FDA determined that the APPY1 diagnostic test did not meet the criteria based on data and information in the 510(k) submission.

Following this news, the price of Venaxis stock declined by $1.49 per share, or over 73%, to close on January 29, 2015 at $0.55 per share.

Request more information now by clicking here: www.faruqilaw.com/APPY. There is no cost or obligation to you.

Take Action

If you invested in Venaxis common stock or options between March 13, 2014 and January 28, 2015 and would like to discuss your legal rights, visit www.faruqilaw.com/APPY. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

Contact Information

  • FARUQI & FARUQI, LLP
    369 Lexington Avenue, 10th Floor
    New York, NY 10017
    Attn: Richard Gonnello, Esq.
    rgonnello@faruqilaw.com
    Telephone: (877) 247-4292 or (212) 983-9330